ChipMOS Technologies Inc (IMOS)vsZepp Health Corp (ZEPP)
IMOS
ChipMOS Technologies Inc
$54.80
+13.83%
TECHNOLOGY · Cap: $1.91B
ZEPP
Zepp Health Corp
$18.01
+2.56%
TECHNOLOGY · Cap: $270.28M
Smart Verdict
WallStSmart Research — data-driven comparison
ChipMOS Technologies Inc generates 9144% more annual revenue ($23.93B vs $258.90M). IMOS leads profitability with a 2.1% profit margin vs -15.5%. IMOS earns a higher WallStSmart Score of 52/100 (C-).
IMOS
Buy52
out of 100
Grade: C-
ZEPP
Hold38
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for IMOS.
Margin of Safety
+48.9%
Fair Value
$46.96
Current Price
$18.01
$28.95 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 126.8% YoY
Reasonable price relative to book value
Revenue surging 20.8% year-over-year
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
Expensive relative to growth rate
Grey zone — moderate risk
Smaller company, higher risk/reward
ROE of 2.0% — below average capital efficiency
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : IMOS
The strongest argument for IMOS centers on EPS Growth, Price/Book, Revenue Growth. Revenue growth of 20.8% demonstrates continued momentum.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : IMOS
The primary concerns for IMOS are PEG Ratio, Altman Z-Score, Market Cap. A P/E of 111.8x leaves little room for execution misses. Thin 2.1% margins leave little buffer for downturns.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
IMOS profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
IMOS generates stronger free cash flow (973M), providing more financial flexibility.
Bottom Line
IMOS scores higher overall (52/100 vs 38/100) and 20.8% revenue growth. ZEPP offers better value entry with a 48.9% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
ChipMOS Technologies Inc
TECHNOLOGY · SEMICONDUCTORS · USA
ChipMOS TECHNOLOGIES INC. The company is headquartered in Hsinchu, Taiwan.
Visit Website →Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SEMICONDUCTORS Stocks
Want to dig deeper into these stocks?